{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T22:44:09Z","timestamp":1773614649939,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"17-18","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00508-019-01543-6","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T14:50:58Z","timestamp":1567781458000},"page":"435-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["How can maturity-onset diabetes of the young be identified among more common diabetes subtypes?"],"prefix":"10.1007","volume":"131","author":[{"given":"Jana","family":"Urbanova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6770-5011","authenticated-orcid":false,"given":"Ludmila","family":"Brunerova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Broz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"1543_CR1","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.2337\/dc11-0035","volume":"34","author":"SS Fajans","year":"2011","unstructured":"Fajans\u00a0SS, Bell\u00a0GI. MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care. 2011;34:1878\u201384.","journal-title":"Diabetes Care"},{"key":"1543_CR2","volume-title":"Maturity-onset diabetes of the young; MODY","author":"Online Mendelian Inheritance in Man, OMIM","year":"2016","unstructured":"Online Mendelian Inheritance in Man, OMIM. Maturity-onset diabetes of the young; MODY. 2016. \n                    http:\/\/mirror.omim.org\/entry\/606391\n                    \n                  . Accessed 15.2019."},{"issue":"6","key":"1543_CR3","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2337\/dc11-1243","volume":"35","author":"G Thanabalasingham","year":"2012","unstructured":"Thanabalasingham\u00a0G, Pal\u00a0A, Selwood\u00a0MP, Dudley\u00a0C, Fisher\u00a0K, Bingley\u00a0PJ, et al. Systematic assessment of etiology in adults with a\u00a0clinical diagnosis of young onset type 2 diabetes is a\u00a0successful strategy for identifying maturity-onset diabetes of the young. Diabetes Care. 2012;35(6):1206\u201312.","journal-title":"Diabetes Care"},{"issue":"1","key":"1543_CR4","doi-asserted-by":"publisher","first-page":"e2940","DOI":"10.1002\/dmrr.2940","volume":"34","author":"L Brunerova","year":"2018","unstructured":"Brunerova\u00a0L, Rahelic\u00a0D, Ceriello\u00a0A, Broz\u00a0J. Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young (MODY): a\u00a0minireview. Diabetes Metab Res Rev. 2018;34(1):e2940.","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"1543_CR5","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1007\/s00125-018-4728-6","volume":"61","author":"MH Shepherd","year":"2018","unstructured":"Shepherd\u00a0MH, Shields\u00a0BM, Hudson\u00a0M, Pearson\u00a0ER, Hyde\u00a0C, Ellard\u00a0S, et\u00a0al. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin. Diabetologia. 2018;61(12):2520\u20137. \n                    https:\/\/doi.org\/10.1007\/s00125-018-4728-6\n                    \n                  .","journal-title":"Diabetologia"},{"key":"1543_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/DMSO.S23353","volume":"5","author":"DS Gardner","year":"2012","unstructured":"Gardner\u00a0DS, Tai\u00a0ES. Clinical features and treatment of maturity onset diabetes of the young (MODY). Diab Meta Syndr Obes Targets Ther. 2012;5:101\u20138. \n                    https:\/\/doi.org\/10.2147\/DMSO.S23353\n                    \n                  .","journal-title":"Diab Meta Syndr Obes Targets Ther"},{"issue":"2","key":"1543_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00125-005-0100-8","volume":"49","author":"EB Tsai","year":"2006","unstructured":"Tsai\u00a0EB, Sherry\u00a0NA, Palmer\u00a0JP. Herold KC The rise and fall of insulin secretion in type 1 diabetes mellitus. Diabetologia. 2006;49(2):261\u201370.","journal-title":"Diabetologia"},{"key":"1543_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11154-006-9014-0","volume":"7","author":"A Slingerland","year":"2006","unstructured":"Slingerland\u00a0A. Monogenic diabetes in children and young adults: challenges for researcher, clinician and patient. Rev Endocr Metab Disord. 2006;7:171\u201385.","journal-title":"Rev Endocr Metab Disord"},{"issue":"9","key":"1543_CR9","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.2337\/dc13-0058","volume":"36","author":"\u0160 Pr\u016fhov\u00e1","year":"2013","unstructured":"Pr\u016fhov\u00e1 \u0160, Du\u0161\u00e1tkov\u00e1\u00a0P, Neumann\u00a0D, Hollay\u00a0E, Cinek\u00a0O, Lebl\u00a0J, et al. Two cases of diabetic ketoacidosis in HNF1A-MODY linked to severe dehydration: is it time to change the diagnostic criteria for MODY? Diabetes Care. 2013;36(9):2573\u20134.","journal-title":"Diabetes Care"},{"issue":"2","key":"1543_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pedi.12553","volume":"19","author":"Y Horikawa","year":"2018","unstructured":"Horikawa\u00a0Y, Enya\u00a0M, Mabe\u00a0H, Fukushima\u00a0K, Takubo\u00a0N, Ohashi\u00a0M, et al. NEUROD1-deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical features. Pediatr Diabetes. 2018;19(2):236\u201342. \n                    https:\/\/doi.org\/10.1111\/pedi.12553\n                    \n                  .","journal-title":"Pediatr Diabetes"},{"key":"1543_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4243784","author":"M Grzanka","year":"2016","unstructured":"Grzanka\u00a0M, Matejko\u00a0B, Szopa\u00a0M, Kiec-Wilk\u00a0B, Malecki\u00a0MT, Klupa\u00a0T. Assessment of newly proposed clinical criteria to identify HNF1A MODY in patients with an initial diagnosis of type 1 or type 2 diabetes mellitus. Adv Med. 2016; \n                    https:\/\/doi.org\/10.1155\/2016\/4243784\n                    \n                  .","journal-title":"Adv Med"},{"issue":"4","key":"1543_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s00125-008-0942-y","volume":"51","author":"S Ellard","year":"2008","unstructured":"Ellard\u00a0S, Bellann\u00e9-Chantelot\u00a0C, Hattersley\u00a0AT. European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia. 2008;51(4):546\u201353.","journal-title":"Diabetologia"},{"issue":"8","key":"1543_CR13","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2337\/dc17-0224","volume":"40","author":"BM Shields","year":"2017","unstructured":"Shields\u00a0BM, Shepherd\u00a0M, Hudson\u00a0M, McDonald\u00a0TJ, Colclough\u00a0K, Peters\u00a0J, et al. Population-based assessment of a\u00a0biomarker-based screening pathway to aid diagnosis of Monogenic diabetes in young-onset patients. Diabetes Care. 2017;40(8):1017\u201325.","journal-title":"Diabetes Care"},{"key":"1543_CR14","doi-asserted-by":"publisher","first-page":"e65326","DOI":"10.1371\/journal.pone.0065326","volume":"8","author":"AM Steele","year":"2013","unstructured":"Steele\u00a0AM, Wensley\u00a0KJ, Ellard\u00a0S, Murphy\u00a0R, Shepherd\u00a0M, Colclough\u00a0K, et\u00a0al. Use of HbA1c in the identification of patients with hyperglycaemia caused by a\u00a0glucokinase mutation: observational case control studies. PLoS ONE. 2013;8:e65326.","journal-title":"PLoS ONE"},{"issue":"1","key":"1543_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00125-013-3075-x","volume":"57","author":"A Stride","year":"2014","unstructured":"Stride\u00a0A, Shields\u00a0B, Gill-Carey\u00a0O, Chakera\u00a0AJ, Colclough\u00a0K, Ellard\u00a0S, et al. Cross sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. Diabetologia. 2014;57(1):54\u20136.","journal-title":"Diabetologia"},{"key":"1543_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/718254","author":"S Pruhova","year":"2013","unstructured":"Pruhova\u00a0S, Dusatkova\u00a0P, Kraml\u00a0PJ, Kulich\u00a0M, Prochazkova\u00a0Z, Broz\u00a0J, et al. Chronic mild hyperglycemia in GCK-MODY patients does not increase carotid intima-media thickness. Int J Endocrinol. 2013; \n                    https:\/\/doi.org\/10.1155\/2013\/718254\n                    \n                  .","journal-title":"Int J Endocrinol"},{"issue":"7","key":"1543_CR17","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2337\/dc14-2769","volume":"38","author":"AJ Chakera","year":"2015","unstructured":"Chakera\u00a0AJ, Steele\u00a0AM, Gloyn\u00a0AL, Shepherd\u00a0MH, Shields\u00a0B, Ellard\u00a0S, et\u00a0al. Recognition and management of individuals with hyperglycaemia because of a\u00a0heterozygous glucokinase mutation. Diabetes Care. 2015;38(7):1383\u201392.","journal-title":"Diabetes Care"},{"issue":"3","key":"1543_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00125-013-3119-2","volume":"57","author":"J Stanik","year":"2014","unstructured":"Stanik\u00a0J, Dusatkova\u00a0P, Cinek\u00a0O, Valentinova\u00a0L, Huckova\u00a0M, Skopkova\u00a0M, et\u00a0al. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed. Diabetologia. 2014;57(3):480\u20134.","journal-title":"Diabetologia"},{"issue":"2","key":"1543_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1464-5491.2009.02913.x","volume":"27","author":"AM Steele","year":"2010","unstructured":"Steele\u00a0AM, Shields\u00a0BM, Shepherd\u00a0M, Ellard\u00a0S, Hattersley\u00a0AT, Pearson\u00a0ER. Increased all-cause and cardiovascular mortality in monogenic diabetes as a\u00a0result of mutations in the HNF1A gene. Diabet Med. 2010;27(2):157\u201361.","journal-title":"Diabet Med"},{"key":"1543_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00125-011-2319-x","volume":"55","author":"P Bowman","year":"2012","unstructured":"Bowman\u00a0P, Flanagan\u00a0SE, Edghill\u00a0EL, Damhuis\u00a0A, Shepherd\u00a0MH, Paisey\u00a0R, et\u00a0al. Heterozygous ABCC8 mutations are a\u00a0cause of MODY. Diabetologia. 2012;55:123\u20137.","journal-title":"Diabetologia"},{"key":"1543_CR21","first-page":"1993","volume-title":"GeneReviews\u00ae","author":"R Naylor","year":"2018","unstructured":"Naylor\u00a0R, Knight Johnson\u00a0A, del Gaudio\u00a0D. Maturity-onset diabetes of the young overview. In: Adam\u00a0MP, Ardinger\u00a0HH, Pagon\u00a0RA, et al., editors. GeneReviews\u00ae. Seattle: University of Washington; 2018. pp. 1993\u20132018. Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500456\/\n                    \n                  ."},{"issue":"12","key":"1543_CR22","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00125-013-3031-9","volume":"56","author":"L Liu","year":"2013","unstructured":"Liu\u00a0L, Nagashima\u00a0K, Yasuda\u00a0T, Liu\u00a0Y, Hu\u00a0HR, He\u00a0G, et al. Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes. Diabetologia. 2013;56(12):2609\u201318.","journal-title":"Diabetologia"},{"issue":"1","key":"1543_CR23","doi-asserted-by":"publisher","first-page":"232470961769871","DOI":"10.1177\/2324709617698718","volume":"5","author":"S Sood","year":"2017","unstructured":"Sood\u00a0S, Landreth\u00a0H, Bustinza\u00a0J, Chalmers\u00a0L, Thukaram\u00a0R. Neonatal diabetes: case report of a\u00a09-week-old presenting diabetic Ketoacidosis Due to an activating ABCC8 gene mutation. Journal of Investigative Medicine High Impact Case Reports. 2017;5(1):2324709617698718.","journal-title":"Journal of Investigative Medicine High Impact Case Reports"},{"issue":"5","key":"1543_CR24","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2337\/diacare.27.5.1102","volume":"27","author":"ER Pearson","year":"2004","unstructured":"Pearson\u00a0ER, Badman\u00a0MK, Lockwood\u00a0CR, Clark\u00a0PM, Ellard\u00a0S, Bingham\u00a0C, et al. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations. Diabetes Care. 2004;27(5):1102\u20137.","journal-title":"Diabetes Care"},{"issue":"12","key":"1543_CR25","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00125-002-0978-3","volume":"45","author":"N Tonooka","year":"2002","unstructured":"Tonooka\u00a0N, Tomura\u00a0H, Takahashi\u00a0Y, Onigata\u00a0K, Kikuchi\u00a0N, Horikawa\u00a0Y, et al. High frequency of mutations in the HNF-1alpha gene in non-obese patients with diabetes of youth in Japanese and identification of a\u00a0case of digenic inheritance. Diabetologia. 2002;45(12):1709\u201312. Dec.","journal-title":"Diabetologia"},{"issue":"2","key":"1543_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrneph.2014.232","volume":"11","author":"RL Clissold","year":"2015","unstructured":"Clissold\u00a0RL, Hamilton\u00a0AJ, Hattersley\u00a0AT, Ellard\u00a0S, Bingham\u00a0C. HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum. Nat Rev Nephrol. 2015;11(2):102\u201312. \n                    https:\/\/doi.org\/10.1038\/nrneph.2014.232\n                    \n                  .","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"1543_CR27","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/j.1464-5491.2006.01999.x","volume":"23","author":"EL Edghill","year":"2006","unstructured":"Edghill\u00a0EL, Bingham\u00a0C, Slingerland\u00a0AS, Minton\u00a0JA, Noordam\u00a0C, Ellard\u00a0S, et al. Hepatocyte nuclear factor\u20111 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a\u00a0critical role of HNF-1beta in human pancreatic development. Diabet Med. 2006;23(12):1301\u20136.","journal-title":"Diabet Med"},{"issue":"2","key":"1543_CR28","first-page":"312","volume":"24","author":"P Weber","year":"2011","unstructured":"Weber\u00a0P, Ambrosova\u00a0P, Canov\u00a0P, Weberova\u00a0D, Kuklinek\u00a0P, Meluzinova\u00a0H, et al. GAD antibodies in T1D and LADA\u2014relations to age, BMI, c\u2011peptide, IA\u20112 and HLA-DRB1*03 and DRB1*04 alleles. Adv Gerontol. 2011;24(2):312\u20138.","journal-title":"Adv Gerontol"},{"issue":"4","key":"1543_CR29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/dme.12314","volume":"31","author":"J Urbanov\u00e1","year":"2014","unstructured":"Urbanov\u00e1\u00a0J, Ryp\u00e1\u010dkov\u00e1\u00a0B, Proch\u00e1zkov\u00e1\u00a0Z, Ku\u010dera\u00a0P, Cern\u00e1\u00a0M, And\u011bl\u00a0M, et\u00a0al. Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level. Diabet Med. 2014;31(4):466\u201371.","journal-title":"Diabet Med"},{"key":"1543_CR30","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.2337\/db07-1467","volume":"57","author":"A Molven","year":"2008","unstructured":"Molven\u00a0A, Ringdal\u00a0M, Nordb\u00f8\u00a0AM, Raeder\u00a0H, St\u00f8y\u00a0J, Lipkind\u00a0GM, et al. Mutation in the insulin gene can cause MODY and antibody-negative type 1 DM. Diabetes. 2008;57:1034\u201342.","journal-title":"Diabetes"},{"issue":"9922","key":"1543_CR31","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn\u00a0SE, Cooper\u00a0ME, Del Prato\u00a0S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present and future. Lancet. 2014;383(9922):1068\u201383. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(13)62154-6\n                    \n                  .","journal-title":"Lancet"},{"key":"1543_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00125-001-0770-9","volume":"45","author":"A Stride","year":"2002","unstructured":"Stride\u00a0A, Vaxillaire\u00a0M, Tuomi\u00a0T, et\u00a0al. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia. 2002;45:427\u201335. \n                    https:\/\/doi.org\/10.1007\/s00125-001-0770-9\n                    \n                  .","journal-title":"Diabetologia"},{"issue":"7","key":"1543_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1046\/j.1464-5491.2000.00305.x","volume":"17","author":"ER Pearson","year":"2000","unstructured":"Pearson\u00a0ER, Liddell\u00a0WG, Shepherd\u00a0M, Corrall\u00a0RJ, Hattersley\u00a0AT. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med. 2000;17(7):543\u20135.","journal-title":"Diabet Med"},{"issue":"8","key":"1543_CR34","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.2337\/dc11-0323","volume":"34","author":"TJ McDonald","year":"2011","unstructured":"McDonald\u00a0TJ, Shields\u00a0BM, Lawry\u00a0J, Owen\u00a0KR, Gloyn\u00a0AL, Ellard\u00a0S, et al. High sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care. 2011;34(8):1860\u20132.","journal-title":"Diabetes Care"},{"issue":"4","key":"1543_CR35","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1371\/journal.pmed.0040118","volume":"4","author":"ER Pearson","year":"2007","unstructured":"Pearson\u00a0ER, Boj\u00a0SF, Steele\u00a0AM, Barrett\u00a0T, Stals\u00a0K, Shield\u00a0JP, et\u00a0al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med. 2007;4(4):e118.","journal-title":"PLoS Med"},{"issue":"1","key":"1543_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.trsl.2010.03.003","volume":"156","author":"SS Fajans","year":"2010","unstructured":"Fajans\u00a0SS, Bell\u00a0GI, Paz\u00a0VP, et\u00a0al. Obesity and hyperinsulinemia in a\u00a0family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60. Transl Res. 2010;156(1):7\u201314.","journal-title":"Transl Res"},{"key":"1543_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/15500","volume":"23","author":"MT Malecki","year":"1999","unstructured":"Malecki\u00a0MT, Jhala\u00a0U, Antonellis\u00a0A, Fields\u00a0L, Doria\u00a0A, Orban\u00a0T, et\u00a0al. Mutations in NEUROD1 are associated with the development of type two diabetes. Nat Genet. 1999;23:323\u20138. \n                    https:\/\/doi.org\/10.1038\/15500\n                    \n                  .","journal-title":"Nat Genet"},{"key":"1543_CR38","doi-asserted-by":"publisher","first-page":"14460","DOI":"10.1073\/pnas.0906474106","volume":"106","author":"M Borowiec","year":"2009","unstructured":"Borowiec\u00a0M, Liew\u00a0CW, Thompson\u00a0R, Boonyasrisawat\u00a0W, Hu\u00a0J, Mlynarski\u00a0WM, et al. Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction. Proc Natl Acad Sci U S\u00a0A. 2009;106:14460\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1543_CR39","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1073\/pnas.0409177102","volume":"102","author":"B Neve","year":"2005","unstructured":"Neve\u00a0B, Fernandez-Zapico\u00a0ME, Ashkenazi-Katalan\u00a0V, Dina\u00a0C, Hamid\u00a0YH, Joly\u00a0E, et al. Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proc Natl Acad Sci U S\u00a0A. 2005;102:4807\u201312. \n                    https:\/\/doi.org\/10.1073\/pnas.0409177102\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1543_CR40","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1210\/jc.2006-1927","volume":"92","author":"N Plengvidhya","year":"2007","unstructured":"Plengvidhya\u00a0N, Kooptiwut\u00a0S, Songtawee\u00a0N, Doi\u00a0A, Furuta\u00a0H, Nishi\u00a0M, et\u00a0al. PAX4 mutations in Thais with maturity onset diabetes of the young. J\u00a0Clin Endocrinol Metab. 2007;92:2821\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"1543_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajhg.2015.05.011","volume":"97","author":"S Prundate","year":"2015","unstructured":"Prundate\u00a0S, Jungtrakoon\u00a0P, Marucci\u00a0A, Ludovico\u00a0O, Buranasupkajorn\u00a0P, Mazza\u00a0T, et al. Loss-of-function mutations in APPL1 in familial diabetes mellitus. Am J Hum Genet. 2015;97:177\u201385. \n                    https:\/\/doi.org\/10.1016\/j.ajhg.2015.05.011\n                    \n                  .","journal-title":"Am J Hum Genet"},{"key":"1543_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ng1708","volume":"38","author":"H Raeder","year":"2006","unstructured":"Raeder\u00a0H, Johansson\u00a0S, Holm\u00a0PI, Haldorsen\u00a0IS, Mas\u00a0E, Sbarra\u00a0V, et\u00a0al. Mutations in the CEL VNTR cause a\u00a0syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet. 2006;38:54\u201362.","journal-title":"Nat Genet"},{"issue":"6","key":"1543_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1210\/js.2017-00040","volume":"1","author":"AP Gjesing","year":"2017","unstructured":"Gjesing\u00a0AP, Rui\u00a0G, Lauenborg\u00a0J, et al. High prevalence of diabetes-predisposing variants in MODY genes among Danish women with gestational diabetes mellitus. J\u00a0Endocr Soc. 2017;1(6):681\u201390. \n                    https:\/\/doi.org\/10.1210\/js.2017-00040\n                    \n                  .","journal-title":"J Endocr Soc"},{"issue":"Suppl. 1","key":"1543_CR44","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetesd 2018. Diabetes Care. 2018;41(Suppl. 1):S13\u2013S27. \n                    https:\/\/doi.org\/10.2337\/dc18-S002\n                    \n                  .","journal-title":"Diabetes Care"},{"key":"1543_CR45","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2337\/dc14-2769","volume":"38","author":"AJ Chakera","year":"2015","unstructured":"Chakera\u00a0AJ, Steele\u00a0AM, Gloyn\u00a0A, et\u00a0al. Recognition and management of individuals with hyperglycemia because of heterozygous glucokinase mutations. Diabetes Care. 2015;38:1383\u201392.","journal-title":"Diabetes Care"},{"key":"1543_CR46","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2337\/dc13-2248","volume":"37","author":"AJ Chakera","year":"2014","unstructured":"Chakera\u00a0AJ, Spyer\u00a0G, Vincent\u00a0N, Ellard\u00a0S, Hattersley\u00a0AT, Dunne\u00a0FP. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort. Diabetes Care. 2014;37:1230\u20136.","journal-title":"Diabetes Care"},{"issue":"1","key":"1543_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2337\/dc15-1001","volume":"39","author":"VL Rudland","year":"2016","unstructured":"Rudland\u00a0VL, Hinchcliffe\u00a0M, Pinner\u00a0J, Cole\u00a0S, Mercorella\u00a0B, et\u00a0al. Identifying glucokinase monogenic diabetes in a\u00a0multiethnic gestational diabetes mellitus cohort: new pregnancy screening criteria and utility of HbA1c. Diabetes Care. 2016;39(1):50\u20132. \n                    https:\/\/doi.org\/10.2337\/dc15-1001\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"12","key":"1543_CR48","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/dme.12830","volume":"32","author":"JR Flack","year":"2015","unstructured":"Flack\u00a0JR, Ross\u00a0GP, Cheung\u00a0NW. GCK monogenic diabetes and gestational diabetes: possible diagnosis on clinical grounds. Diabet Med. 2015;32(12):1596\u2013601. \n                    https:\/\/doi.org\/10.1111\/dme.12830\n                    \n                  .","journal-title":"Diabet Med"},{"issue":"5","key":"1543_CR49","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jcjd.2015.11.004","volume":"40","author":"CH Lachance","year":"2016","unstructured":"Lachance\u00a0CH. Practical aspects of monogenic diabetes: a clinical point of view. Canadian Journal of Diabetes. 2016;40(5):368\u201375.","journal-title":"Canadian Journal of Diabetes"},{"key":"1543_CR50","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1210\/jc.2011-0268","volume":"96","author":"C Bellann\u00e9-Chantelot","year":"2011","unstructured":"Bellann\u00e9-Chantelot\u00a0C, L\u00e9vy\u00a0DJ, Carette\u00a0C, Saint-Martin\u00a0C, Riveline\u00a0JP, Larger\u00a0E, et al. Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene. J\u00a0Clin Endocrinol Metab. 2011;96:1346\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1543_CR51","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4093\/dmj.2015.39.6.468","volume":"39","author":"K Sung-Hoon","year":"2015","unstructured":"Sung-Hoon\u00a0K. Maturity-onset diabetes of the young: what do clinicians need to know? Diabetes Metab\u00a0J. 2015;39(6):468\u201377.","journal-title":"Diabetes Metab J"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-019-01543-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-019-01543-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-019-01543-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T23:33:16Z","timestamp":1599262396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-019-01543-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":51,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1543"],"URL":"https:\/\/doi.org\/10.1007\/s00508-019-01543-6","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"15 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0Urbanova, L.\u00a0Brunerova, and J.\u00a0Broz declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}